Recent studies confirm increased CD38 expression in SLE CD4+ T cells correlates with increased lipid rafts, and targeting CD38 to modulate ganglioside GM2 distribution alleviates SLE pathology (161). Here, CD4 is linked to systemic lupus erythematosus.